Global Bone Growth Stimulator Market Insights Forecasts to 2032

• The Global Bone Growth Stimulator Market Size was valued at USD 1.30 Billion in 2022.
• The Market Size is Growing at a CAGR of 5.8% from 2022 to 2032.
• The Worldwide Bone Growth Stimulator Market Size is expected to reach USD 2.28 Billion by 2032
• Asia Pacific is expected To Grow higher during the forecast period

 

Get more details on this report -

Request Free Sample PDF

  

The Global Bone Growth Stimulator Market Size is expected to reach USD 2.28 Billion by 2032, at a CAGR of 5.8% during the forecast period 2022 to 2032.

 

Market Overview

A Bone Growth Stimulator is a medical device designed to accelerate and promote the natural healing process of bone fractures and non-unions. It employs various technologies, such as low-intensity pulsed ultrasound (LIPUS) or pulsed electromagnetic fields (PEMF), to stimulate cellular activity and enhance blood flow around the affected area. By delivering targeted, safe, and non-invasive energy to the fracture site, these stimulators encourage the formation of new bone tissue, reducing healing time and increasing the likelihood of successful bone union. Bone Growth Stimulators are commonly used in cases where fractures are slow to heal or have shown resistance to conventional treatments. This innovative therapy provides a promising alternative to conventional interventions, facilitating better recovery and improved patient outcomes.

 

Report Coverage

This research report categorizes the market for bone growth stimulator market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the bone growth stimulator market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the bone growth stimulator market.

 

Driving Factors

The bone growth stimulator market is driven by several key factors that contribute to its growth and widespread adoption, such as the aging population across the globe is experiencing an increase in orthopedic conditions, such as fractures and bone-related ailments, leading to a higher demand for bone growth stimulators. As the elderly are more prone to bone-related issues, the need for effective and non-invasive treatments like bone growth stimulators becomes crucial. The advancements in medical technology and research have resulted in the development of more sophisticated and efficient bone growth stimulator devices. These technological innovations have led to improved treatment outcomes, reduced side effects, and enhanced patient comfort, further boosting market growth. The rising prevalence of sports injuries and road accidents has also driven the demand for bone growth stimulators. As sports and vehicular accidents often result in bone fractures and non-unions, the utilization of bone growth stimulators as an adjunct therapy to expedite healing has become increasingly common. Furthermore, the increasing awareness among patients and healthcare professionals about the benefits of bone growth stimulators has positively impacted market growth. As more research and clinical evidence demonstrate the efficacy of these devices, their acceptance and incorporation into treatment regimens have grown. Lastly, favorable reimbursement policies and insurance coverage for bone growth stimulators have encouraged patients to opt for this treatment, further contributing to market expansion.

 

Restraining Factors

The bone growth stimulator market also faces several restraints that hinder its growth and adoption. Such as the high cost of these devices poses a significant barrier, limiting access for patients with financial constraints. The lack of reimbursement options or inadequate coverage by insurance companies in certain regions makes it challenging for patients to afford these treatments. Additionally, the efficacy of bone growth stimulators may vary among individuals, leading to skepticism among some healthcare professionals and patients. Moreover, the stringent regulatory approval processes for these devices can delay their market entry.

 

Market Segmentation

• In 2022, the bone growth stimulation devices segment accounted for around 35.4% market share

On the basis of the material type, the global bone growth stimulator market is segmented into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. The bone growth stimulation devices segment held the largest market share due to increasing aging population across the globe is more susceptible to bone fractures and related ailments, driving the demand for these devices. Advancements in medical technology have led to the development of more efficient and sophisticated bone growth stimulator devices, enhancing their effectiveness and acceptance. Moreover, the rising incidence of sports injuries and road accidents has further boosted the adoption of bone growth stimulators as an adjunct therapy for faster healing. Additionally, the segment's dominance is attributed to growing awareness and acceptance among healthcare professionals and patients about their therapeutic benefits.

 

• The spinal fusion surgeries segment held the largest market over the forecast period

Based on the application, the global bone growth stimulator market is segmented into spinal fusion surgeries, delayed union & nonunion bone fractures, oral & maxillofacial surgeries, and others. The spinal fusion surgeries segment held the largest market over the forecast period due to a growing prevalence of degenerative spine disorders, such as herniated discs and spinal stenosis, leading to an increased demand for spinal fusion procedures to alleviate pain and stabilize the spine. The advancements in surgical techniques and technologies have improved the success rates of spinal fusion surgeries, making them a preferred choice for treating various spinal conditions. Moreover, the segment's growth is driven by the rising geriatric population, which is more prone to age-related spine problems, further boosting the demand for spinal fusion surgeries as an effective treatment option.

 

• The hospitals & ambulatory surgical centers segment held the largest market

Based on the end-user, the global bone growth stimulator market is segmented into hospitals & ambulatory surgical centers, home care settings, and academic & research institutes. The hospitals & ambulatory surgical centers segment held the largest market share for several reasons, such as the hospitals are major healthcare facilities that handle a wide range of medical conditions, including orthopedic and spine-related issues, leading to a higher demand for bone growth stimulators. Additionally, ambulatory surgical centers offer outpatient surgical procedures, providing a convenient and cost-effective setting for patients who require bone growth stimulation treatments without an extended hospital stay. Moreover, these facilities are well-equipped with advanced medical technologies and skilled healthcare professionals, making them ideal settings for bone growth stimulator procedures, thereby contributing to the segment's dominant market position.

 

Regional Segment Analysis of the Bone Growth Stimulator Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America dominated the market with more than 44.5% revenue share in 2022.

 

Get more details on this report -

Request Free Sample PDF

 

 North America's dominance in the bone growth stimulator market can be attributed to several factors. The region has a substantial geriatric population, leading to a higher incidence of bone-related ailments, driving demand for these devices. Additionally, North America is at the forefront of medical research and technological advancements, leading to the development of cutting-edge bone growth stimulator devices. Furthermore, the presence of well-established healthcare infrastructure, supportive reimbursement policies, and high healthcare spending further contributes to the region's largest market share in this sector.

 

Asia-Pacific's projected rapid growth in the bone growth stimulator market during the forecast period can be attributed to several factors. The region's large and aging population is prone to orthopedic conditions, increasing the demand for bone growth stimulators. Moreover, improving healthcare infrastructure and rising disposable incomes allow greater accessibility to advanced medical technologies. Additionally, a surge in sports-related injuries and road accidents necessitates effective treatments like bone growth stimulators.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global bone growth stimulator market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Companies:

• Orthofix Medical Inc.
• Enovis Corporation
• ZimVie
• Bioventus LLC
• Medtronic PLC
• Terumo Corporation
• Ossatec Benelux BV
• BTT Health GmbH
• Stimulate Health
• Isto Biologics
• Colfax Corporation

 

Key Target Audience

• Market Players
• Investors
• End-Users
• Government Authorities 
• Consulting and Research Firm
• Venture Capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In May 2022, Orthofix Medical Inc. (US) obtained FDA premarket approval for the AccelStim Bone Growth Stimulation Device. This approval signifies that the device has met the necessary regulatory requirements and can now be marketed and sold in the United States. The AccelStim Bone Growth Stimulation Device is expected to offer advanced therapeutic options for promoting bone healing and treating fractures effectively.

 

• In March 2022, the corporation announced the competition of ZimVie, its offshoot. The separation represents a significant step forward in Zimmer Biomet's active portfolio management.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global bone growth stimulator market based on the below-mentioned segments:

 

Bone Growth Stimulator Market, By Material Type

• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins
• Platelet-Rich Plasma

 

Bone Growth Stimulator Market, By Application

• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries
• Others

 

Bone Growth Stimulator Market, By End-User

• Hospitals & Ambulatory Surgical Centers
• Home Care Settings
• Academic & Research Institutes

 

Bone Growth Stimulator Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa